Contract Development and Manufacturing Organizations (CDMOs) face many unique challenges. As an outsourced solutions partner that is responsible for some of the most critical elements of success for their client’s product there is a constant demand for the highest quality product to be delivered under tight time tables with efficient processes and information sharing.
Lab Owl can help CDMOs stabilize and improve lab performance to exceed their client’s complex development and manufacturing expectations.
Biotech and life science organizations are increasingly looking to CDMOs for process development and manufacturing expertise, as opposed to multiple contract research organizations (CROs) or contract manufacturing organizations (CMOs).
In recent years the CDMO market has started to change with larger CDMOs purchasing smaller niche CROs and CMOs. What was once a fragmented CDMO landscape is consolidating, which means life science companies can increasingly partner with a single CDMO for all of their R&D and manufacturing needs. By engaging a single, full-service CDMO with a broader array of services, biotech and life science companies aim to streamline their supply chain, reduce costs and shorten the timeline to market.
While the industry is consolidating and is in some ways less fragmented, integration remains a big challenge. If a bioscience company chooses to partner with multiple CROs and CMOs, the supply chain and processes can become siloed; on the other hand, if that same company partners with a single CDMO, they are engaging what could be virtual extensions of entire functions that exist entirely outside their organization.
In either case, information sharing becomes a challenge and siloed data can breed bottlenecks and inefficiency. A push for stronger integration to break down these silos has become of paramount importance to both CDMOs and their industry partners.
A recent 2019 post by Kieran Crowley, Ph.D., on the Pharmaceutical Outsourcing website highlighted the critical nature of breaking down silos and fostering stronger integration when it comes to CDMOs: “As the industry changes, drug development companies need new strategies to help them overcome a multitude of research challenges and achieve milestones as quickly as possible. Specifically, we are seeing innovation in the service sector where a focus on smarter R&D has aligned multiple CDMO and CRO activities into a highly integrated model that takes place with a single vendor, under a compressed timeline.”
“This model has broken down barriers, created an opportunity to improve efficiencies, and fostered a consistent exchange of information that allows the outsourcing partner to coordinate and adapt the drug product manufacturing requirements (‘make’) with the specific needs of the clinical development plan (‘test’),” continued Crowley.
What’s important to remember is that this need for efficient and effective integration cuts across all aspects of CDMOs and their bioscience partners, including automated bioreactor control systems. As CDMOs merge with CROs and CMOs, processes, people and entire R&D technology systems need to be integrated into a new and better organization.
“CDMO industry consolidation, when coupled with greater demand for R&D and manufacturing flexibility and complexity (particularly in the area of cell and gene therapy), has increased the need for highly flexible, modular bioreactor control systems. Rigid, cookie-cutter automated control systems are not equipped to handle the M&A system transition and the evolving R&D and manufacturing needs of the life science industry, “stated Michael Blechman, CEO of Lab Owl and its parent company, Automated Control Concepts, Inc.
Lab Owl offers CDMOs stability and greater capabilities as they strive to navigate the M&A transition and better meet the needs of their bioscience clients. Lab Owl is a technology agnostic, open platform that is extremely flexible. The Lab Owl bioreactor control and information system is a technically advanced, modular and scalable solution for complex cell culture and fermentation processes that are essential to efficient and accurate development outcomes. Lab Owl stabilizes lab performance at a reasonable cost and is also able to adjust and scale as a CDMO grows and its client’s R&D and manufacturing requirements evolve.
Lab Owl is an alternative to one-size-fits-all, expensive automation products that make systems integration a nightmare and are ill fit for the rapidly evolving and complex R&D ecosystem.
LabOwl Benefits for CDMOs
Drawing on its deep, wide-ranging systems integration experience across an array of industries, ACC built Lab Owl to empower labs to do more, faster, while maintaining the highest quality assurance standards. LabOwl offers myriad benefits to CDMOs, including:
- Easy setup and scalability. In just a few simple steps, the Lab Owl system can be configured to achieve your unique experiment goals. The interface was designed to be easy to use for everyone, from your lab techs to your Research Directors. The technology can also grow as you grow, helping your scientists from development through scale-up into manufacturing.
- Outstanding Flexibility. Lab Owl was built as an open system to accommodate a wide range of control devices and instrumentation, making it an ideal solution no matter what kind of bioreactors or other technology you utilize in your lab. Any user can also easily set control schemes and custom recipes using macros to automate their unique processes to achieve consistent results. Now you have the ability to easily run the experiments exactly how you want to so you can advance your research without limitations. If you need to extend capabilities, LabOwl was built for easy “plug and play” upgrades.
- Secure, Remote Monitoring. Scientists no longer have to come to the lab in the middle of the night to monitor and fix runs. Monitoring and control can all be done remotely, with push notifications, including alarms, sent right to a device. Automation and remote monitoring reduces staff burnout and can vastly reduce human error.
- Data Collection & Reporting. Lab Owl not only records data from your bioreactors, but it also captures data output from all integrated analytical instruments. The collection of all your data makes it easier to identify run issues and to fix them. The system empowers your team to quickly solve issues and identify what’s working so you can do more of it, more efficiently.
- Outstanding, Ongoing Support. You and your scientists will have access to ongoing, expert customer support from day one. Installation and setup are just the starts of a long-term consultative support relationship that lets you focus on your research knowing we’re there to make sure your technology is always working the way you need it to.
- Strong Return on Investment. When compared to other automated control systems, Lab Owl is affordable and, even more importantly, you only pay for what you need. As your needs change, as you grow, you can make strategic, easily implemented upgrades so the platform can grow with you.
Lab Owl is a true game-changer for labs and for CDMOs that live and die on their ability to perform consistently, produce accurate and reliable data and remain agile as their client’s needs change. Our product is an extension of our wider mission: To improve our customer’s laboratory and manufacturing operations through the strategic use of technology.
By always keeping your best interests in mind, we’ve developed a solution with a powerful suite of benefits that can truly help your CDMO more quickly integrate newly acquired technology while enhancing your lab team’s performance and productivity.
Integration and agility is the name of the game for CDMOs. Lab Owl can give you both and much more at an affordable price.